I think there is plenty to find out. This is one the graphs that creates doubts in my mind from the earlier cited papers.You can see that in the cisplatin treated mice BL helps recover SIRT1 and SIRT3. But the impact of BL on healthy mice SIRT levels is more or less zero. So the claim that it acts like the CR mechanism is not supported by that graph at least for the healthy mice.The mice used were only 8 weeks old so perhaps the effect may be different in aging mice that have declining SIRT levels.
This is a reasonable conclusion. Very young mice at 8 weeks are unlikely to benefit from it as they already presumably have optimal levels. We have found this working in Senolytics too, very old mice benefit but very young mice do not because they have not developed the declines associated with aging so there is nothing to treat. I would not be at all surprised to see exactly the same with BL here because again a young mouse does not need repairing.
The graphs also show that the SIRT levels dont recover to the heathy mice level with BL treatment. Why is that? Still not enough NAD+ in the cell? Another rate limiting mechanism? This is one of the reasons I would love to see graphs showing the absolute values of NAD+ instead of the ratio's.
It may be as simple as not enough induction from the dosage. Bearing in mind the optimal dosage and frequency are yet to be established. So increasing the dose could well increase that NAD+ ratio. This is very easy to investigate and I could design a test group to estalish the dosage rapidly.
To conclude there is in my view sufficient data to suggest that BL may be able to upregulate the master controller NQ01 and as it is a primary target far upstream worth investigating.
I am interested in further mouse testing with BL. In your opinion, what might be the interaction between beta lapachone and rapamycin? Both partially overlap CR in terms of gene activation. I have had pure BL synthesized - several of us are thinking of testing it on ourselves.
Edited by to age or not to age, 21 October 2016 - 06:03 PM.